ArticleCardiovascular diabetology2014

Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice.

Lin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.